These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 31332714

  • 1. Rutin and Selenium Co-administration Reverse 3-Nitropropionic Acid-Induced Neurochemical and Molecular Impairments in a Mouse Model of Huntington's Disease.
    Abdelfattah MS, Badr SEA, Lotfy SA, Attia GH, Aref AM, Abdel Moneim AE, Kassab RB.
    Neurotox Res; 2020 Jan; 37(1):77-92. PubMed ID: 31332714
    [Abstract] [Full Text] [Related]

  • 2. Effect of rutin against a mitochondrial toxin, 3-nitropropionicacid induced biochemical, behavioral and histological alterations-a pilot study on Huntington's disease model in rats.
    Suganya SN, Sumathi T.
    Metab Brain Dis; 2017 Apr; 32(2):471-481. PubMed ID: 27928694
    [Abstract] [Full Text] [Related]

  • 3. Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
    Thangarajan S, Ramachandran S, Krishnamurthy P.
    Biomed Pharmacother; 2016 Dec; 84():514-525. PubMed ID: 27690136
    [Abstract] [Full Text] [Related]

  • 4. Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington's disease model in rats: emphasis on Sirt1/Nrf2 signaling pathway.
    Ibrahim WW, Abdel Rasheed NO.
    Inflammopharmacology; 2022 Oct; 30(5):1745-1758. PubMed ID: 35639233
    [Abstract] [Full Text] [Related]

  • 5. Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone.
    Kumar P, Kalonia H, Kumar A.
    Br J Pharmacol; 2011 Sep; 164(2b):644-54. PubMed ID: 21486276
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective activity of tetramethylpyrazine against 3-nitropropionic acid induced Huntington's disease-like symptoms in rats.
    Danduga RCSR, Dondapati SR, Kola PK, Grace L, Tadigiri RVB, Kanakaraju VK.
    Biomed Pharmacother; 2018 Sep; 105():1254-1268. PubMed ID: 30021362
    [Abstract] [Full Text] [Related]

  • 7. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats.
    Colle D, Santos DB, Moreira EL, Hartwig JM, dos Santos AA, Zimmermann LT, Hort MA, Farina M.
    PLoS One; 2013 Sep; 8(6):e67658. PubMed ID: 23799154
    [Abstract] [Full Text] [Related]

  • 8. Pretreatment with Bacopa monnieri extract offsets 3-nitropropionic acid induced mitochondrial oxidative stress and dysfunctions in the striatum of prepubertal mouse brain.
    Shinomol GK, Bharath MM, Muralidhara.
    Can J Physiol Pharmacol; 2012 May; 90(5):595-606. PubMed ID: 22472017
    [Abstract] [Full Text] [Related]

  • 9. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines.
    Wang SW, Wang YJ, Su YJ, Zhou WW, Yang SG, Zhang R, Zhao M, Li YN, Zhang ZP, Zhan DW, Liu RT.
    Neurotoxicology; 2012 Jun; 33(3):482-90. PubMed ID: 22445961
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroprotective effect of rutin against colistin-induced oxidative stress, inflammation and apoptosis in rat brain associated with the CREB/BDNF expressions.
    Çelik H, Kandemir FM, Caglayan C, Özdemir S, Çomaklı S, Kucukler S, Yardım A.
    Mol Biol Rep; 2020 Mar; 47(3):2023-2034. PubMed ID: 32030599
    [Abstract] [Full Text] [Related]

  • 13. Rutin inhibits amylin-induced neurocytotoxicity and oxidative stress.
    Yu XL, Li YN, Zhang H, Su YJ, Zhou WW, Zhang ZP, Wang SW, Xu PX, Wang YJ, Liu RT.
    Food Funct; 2015 Oct; 6(10):3296-306. PubMed ID: 26242245
    [Abstract] [Full Text] [Related]

  • 14. Effect of embelin against 3-nitropropionic acid-induced Huntington's disease in rats.
    Dhadde SB, Nagakannan P, Roopesh M, Anand Kumar SR, Thippeswamy BS, Veerapur VP, Badami S.
    Biomed Pharmacother; 2016 Feb; 77():52-8. PubMed ID: 26796265
    [Abstract] [Full Text] [Related]

  • 15. Neuroprotective Efficiency of Prodigiosins Conjugated with Selenium Nanoparticles in Rats Exposed to Chronic Unpredictable Mild Stress is Mediated Through Antioxidative, Anti-Inflammatory, Anti-Apoptotic, and Neuromodulatory Activities.
    Albrakati A, Alsharif KF, Al Omairi NE, Alsanie WF, Almalki ASA, Abd Elmageed ZY, Elshopakey GE, Lokman MS, Bauomy AA, Abdel Moneim AE, Kassab RB.
    Int J Nanomedicine; 2021 Feb; 16():8447-8464. PubMed ID: 35002238
    [Abstract] [Full Text] [Related]

  • 16. Anti-Huntington's Effect of Rosiridin via Oxidative Stress/AchE Inhibition and Modulation of Succinate Dehydrogenase, Nitrite, and BDNF Levels against 3-Nitropropionic Acid in Rodents.
    Afzal M, Sayyed N, Alharbi KS, Alzarea SI, Alshammari MS, Alomar FA, Alenezi SK, Quazi AM, Alzarea AI, Kazmi I.
    Biomolecules; 2022 Jul 23; 12(8):. PubMed ID: 35892333
    [Abstract] [Full Text] [Related]

  • 17. Inosine attenuates 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats via the activation of the A2AR/BDNF/TrKB/ERK/CREB signaling pathway.
    El-Shamarka ME, El-Sahar AE, Saad MA, Assaf N, Sayed RH.
    Life Sci; 2022 Jul 01; 300():120569. PubMed ID: 35472453
    [Abstract] [Full Text] [Related]

  • 18. ADIOL protects against 3-NP-induced neurotoxicity in rats: Possible impact of its anti-oxidant, anti-inflammatory and anti-apoptotic actions.
    Hanna DM, Tadros MG, Khalifa AE.
    Prog Neuropsychopharmacol Biol Psychiatry; 2015 Jul 03; 60():36-51. PubMed ID: 25689821
    [Abstract] [Full Text] [Related]

  • 19. Parthenolide ameliorates 3-nitropropionic acid-induced Huntington's disease-like aberrations via modulating NLRP3 inflammasome, reducing microglial activation and inducing astrocyte shifting.
    Noureldeen ME, Shahin NN, Amin HAA, El-Sawalhi MM, Ghaiad HR.
    Mol Med; 2024 Sep 26; 30(1):158. PubMed ID: 39327568
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.